Irvine News Today | 2 Min News | The Daily News Now!
The FDA is expediting reviews for three psychedelic drugs, including psilocybin and methylone, to treat depression and PTSD, following President Trumps executive order. These drugs, still illegal federally, could see approval within weeks, with veterans and supporters eager for their use. Additionally, the FDA approved early tests for a safer ibogaine metabolite to help with alcohol addiction. This marks a significant shift as small drugmakers, backed by tech investors, push for FDA nods on psychedelics.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/381fd7b5a8e68030